Clinical phenotyping is key to differentiating RFC1 -associated neuropathy from immune-mediated neuropathy.

This scientific commentary refers to 'Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies', by Nagy et al . (https://doi.org/10.1093/braincomms/fcae163).